Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.210
+0.250 (12.76%)
At close: Nov 1, 2024, 4:00 PM
2.230
+0.020 (0.90%)
After-hours: Nov 1, 2024, 6:02 PM EDT

Caribou Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
200507383908--
Market Cap Growth
-43.20%32.27%-57.82%---
Enterprise Value
-8513768473--
Last Close Price
2.215.736.2815.09--
PE Ratio
--4.14-3.84-7.14--
PS Ratio
5.8814.7027.6694.63--
PB Ratio
0.641.381.272.34--
P/FCF Ratio
-1.13-4.83-3.93-26.22--
P/OCF Ratio
-1.23-5.43-4.21-27.93--
EV/Sales Ratio
-5.153.994.9449.28--
EV/EBITDA Ratio
1.24-1.22-0.65-7.17--
EV/EBIT Ratio
1.21-1.18-0.64-7.06--
EV/FCF Ratio
1.30-1.31-0.70-13.65--
Debt / Equity Ratio
0.090.070.09-0.090.00
Debt / FCF Ratio
-0.20-0.26-0.28--0.05-0.01
Asset Turnover
0.090.090.030.040.25-
Quick Ratio
8.5511.758.9714.871.705.30
Current Ratio
8.7511.979.2515.151.965.66
Return on Equity (ROE)
-42.57%-30.50%-28.87%-32.99%-102.92%-
Return on Assets (ROA)
-24.49%-18.00%-16.30%-17.50%-46.09%-
Return on Capital (ROIC)
-27.92%-20.03%-18.56%-20.55%-65.87%-
Earnings Yield
-61.81%-20.14%-25.95%-7.37%--
FCF Yield
-65.57%-20.70%-25.43%-3.81%--
Buyback Yield / Dilution
-44.07%-21.39%-92.02%-270.47%-2.05%-
Total Shareholder Return
-44.07%-21.39%-92.02%-270.47%-2.05%-
Source: S&P Capital IQ. Standard template. Financial Sources.